Calin Buzea

Dr. Calin Buzea

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
RBRazvan Buga
Razvan Buga
CBCalin Buzea
Calin Buzea
Maricel AgopMaricel Agop
Maricel Agop
Lacramioara OchiuzLacramioara Ochiuz
Lacramioara Ochiuz
DVDECEBAL VASINCU
DECEBAL VASINCU
LELucian Eva
Lucian Eva
Background/Objective: This study explores the use of AI-powered radiomics to classify and monitor brain metastasis progression and regression following Gamma Knife radiosurgery (GKRS) based on MRI imaging. A clinical decision support application was developed using Streamlit to provide real-time, AI-driven predictions for treatment monitoring. Methods: MRI scans from 60 patients (3194 images) were analyzed using a transfer learning-enhanced AlexNet deep learning model. Class imbalance was mitigated through dynamic class weighting and data augmentation to ensure equitable performance across all classes. Optimized preprocessing pipelines ensured dataset standardization. Model performance was evaluated using accuracy, precision, recall, F1-scores, and AUC, with 95% confidence intervals. Additionally, a comparative analysis of Gamma Knife radiosurgery (GKRS) outcomes and predictive modeling demonstrated strong correlations between tumor volume evolution and treatment response. The AI predictions and visualizations were integrated into a Streamlit-based application to ensure clinical usability and ease of access. The AI-driven approach effectively classified progression and regression patterns, reinforcing its potential for clinical integration. Results: The transfer learning model achieved flawless classification accuracy (100%; 95% CI: 100–100%) along with perfect precision, recall, and F1-scores. The AUC score of 1.0000 (95% CI: 1.0000–1.0000) indicated excellent discrimination between progression and regression cases. Compared to the baseline AlexNet model (99.53% accuracy; 95% CI: 98.90–100.00%), the TL-enhanced model resolved all misclassifications. Tumor volume analysis identified the baseline size as a key predictor of progression (Pearson r = 0.795, r = 0.795, r = 0.795, p < 0.0001, p < 0.0001, and p < 0.0001). The training time (420.12 s) was faster than ResNet-50 (443.38 s) and EfficientNet-B0 (439.87 s), while achieving equivalent metrics. Despite 100% accuracy, the model requires multi-center validation for generalizability. Conclusions: This study demonstrates that transfer learning with dynamic class weighting provides a highly accurate and reliable framework for monitoring brain metastases post-GKRS. The Streamlit-based AI application enhances clinical decision-making by improving diagnostic precision and reducing variability. Explainable AI techniques, such as Grad-CAM visualizations, improve interpretability and support clinical adoption. These findings emphasize the transformative potential of AI in personalized treatment strategies, extending applications to genomic profiling, survival modeling, and longitudinal follow-ups for brain metastasis management.

23 December 2020 in Medicina
Verified
Journal Article
Open access
PDF file
CMCamil Mirestean
Camil Mirestean
ACAnda Elena Crișan
Anda Elena Crișan
CBCalin Buzea
Calin Buzea
IIIancu Roxana Irina
Iancu Roxana Irina
DIDragoș Petru Teodor Iancu
Dragoș Petru Teodor Iancu
The combination of immune checkpoint inhibitors and definitive radiotherapy is investigated for the multimodal treatment of cisplatin non-eligible locally advanced head and neck cancers (HNC). In the case of recurrent and metastatic HNC, immunotherapy has shown benefit over the EXTREME protocol, being already considered the standard treatment. One of the biggest challenges of multimodal treatment is to establish the optimal therapy sequence so that the synergistic effect is maximal. Thus, superior results were obtained for the administration of anti-CTLA4 immunotherapy followed by hypofractionated radiotherapy, but the anti-PD-L1 therapy demonstrates the maximum potential of radio-sensitization of the tumor in case of concurrent administration. The synergistic effect of radiotherapy–immunotherapy (RT–IT) has been demonstrated in clinical practice, with an overall response rate of about 18% for HNC. Given the demonstrated potential of radiotherapy to activate the immune system through already known mechanisms, it is necessary to identify biomarkers that direct the “nonresponders” of immunotherapy towards a synergistic RT–IT stimulation strategy. Stimulation of the immune system by irradiation can convert “nonresponder” to “responder”. With the development of modern techniques, re-irradiation is becoming an increasingly common option for patients who have previously been treated with higher doses of radiation. In this context, radiotherapy in combination with immunotherapy, both in the advanced local stage and in recurrent/metastatic of HNC radiotherapy, could evolve from the “first level” of knowledge (i.e., ballistic precision, dose conformity and homogeneity) to “level two” of “biological dose painting” (in which the concept of tumor heterogeneity and radio-resistance supports the need for doses escalation based on biological criteria), and finally to the “third level“ ofthe new concept of “immunological dose painting”. The peculiarity of this concept is that the radiotherapy target volumes and tumoricidal dose can be completely reevaluated, taking into account the immune-modulatory effect of irradiation. In this case, the tumor target volume can include even the tumor microenvironment or a partial volume of the primary tumor or metastasis, not all the gross and microscopic disease. Tumoricidal biologically equivalent dose (BED) may be completely different from the currently estimated values, radiotherapy treating the tumor in this case indirectly by boosting the immune response. Thus, the clinical target volume (CTV) can be replaced with a new immunological-clinical target volume (ICTV) for patients who benefit from the RT–IT association (Image 1).

7 February 2025 in Tomography
Verified
Journal Article
Open access
PDF file
SVSimona-Ruxandra Volovat
Simona-Ruxandra Volovat
DPDiana Ioana Panaite
Diana Ioana Panaite
MOMădălina Raluca Ostafe
Mădălina Raluca Ostafe
CBCalin Buzea
Calin Buzea
Maricel AgopMaricel Agop
Maricel Agop
CVCristian Volovat
Cristian Volovat
Background/Objectives: This study explores the application of vision transformers to predict early responses to stereotactic radiosurgery in patients with brain metastases using minimally pre-processed magnetic resonance imaging scans. The objective is to assess the potential of vision transformers as a predictive tool for clinical decision-making, particularly in the context of imbalanced datasets. Methods: We analyzed magnetic resonance imaging scans from 19 brain metastases patients, focusing on axial fluid-attenuated inversion recovery and high-resolution contrast-enhanced T1-weighted sequences. Patients were categorized into responders (complete or partial response) and non-responders (stable or progressive disease). Results: Despite the imbalanced nature of the dataset, our results demonstrate that vision transformers can predict early treatment responses with an overall accuracy of 99%. The model exhibited high precision (99% for progression and 100% for regression) and recall (99% for progression and 100% for regression). The use of the attention mechanism in the vision transformers allowed the model to focus on relevant features in the magnetic resonance imaging images, ensuring an unbiased performance even with the imbalanced data. Confusion matrix analysis further confirmed the model’s reliability, with minimal misclassifications. Additionally, the model achieved a perfect area under the receiver operator characteristic curve (AUC = 1.00), effectively distinguishing between responders and non-responders. Conclusions: These findings highlight the potential of vision transformers, aided by the attention mechanism, as a non-invasive, predictive tool for early response assessment in clinical oncology. The vision transformer (ViT) model employed in this study processes MRIs as sequences of patches, enabling the capture of localized tumor features critical for early response prediction. By leveraging patch-based feature learning, this approach enhances robustness, interpretability, and clinical applicability, addressing key challenges in tumor progression prediction following stereotactic radiosurgery (SRS). The model’s robust performance, despite the dataset imbalance, underscores its ability to provide unbiased predictions. This approach could significantly enhance clinical decision-making and support personalized treatment strategies for brain metastases. Future research should validate these findings in larger, more diverse cohorts and explore the integration of additional data types to further optimize the model’s clinical utility.

10 September 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
MPMaria Valentina Popa
Maria Valentina Popa
CBCalin Buzea
Calin Buzea
IGIrina Gurzu
Irina Gurzu
CSCamer Salim
Camer Salim
BGBogdan Gurzu
Bogdan Gurzu
LDLetitia Doina Duceac
Letitia Doina Duceac
Background: Healthcare workers face multiple, interlinked occupational health risks—burnout, post-COVID-19 sequelae (Long COVID), and extended medical leave. These outcomes often share predictors, contribute to each other, and, together, impact workforce capacity. Yet, existing tools typically address them in isolation. Objective: The objective of this study to develop and deploy an integrated, explainable artificial intelligence (AI) framework that predicts these three outcomes using the same structured occupational health dataset, enabling unified workforce risk monitoring. Methods: We analyzed data from 1244 Romanian healthcare professionals with 14 demographic, occupational, lifestyle, and comorbidity features. For each outcome, we trained a separate predictive model within a common framework: (1) a lightweight transformer neural network with hyperparameter optimization, (2) a transformer with multi-head attention, and (3) a stacked ensemble combining transformer, XGBoost, and logistic regression. The data were SMOTE-balanced and evaluated on held-out test sets using Accuracy, ROC-AUC, and F1-score, with 10,000-iteration bootstrap testing for statistical significance. Results: The stacked ensemble achieved the highest performance: ROC AUC = 0.70 (burnout), 0.93 (Long COVID), and 0.93 (extended leave). The F1 scores were >0.89 for Long COVID and extended leave, whereas the performance gains for burnout were comparatively modest, reflecting the multidimensional and heterogeneous nature of burnout as a binary construct. The gains over logistic regression were statistically significant (p < 0.0001 for Long COVID and extended leave; p = 0.0355 for burnout). The SHAP analysis identified overlapping top predictors—tenure, age, job role, cancer history, pulmonary disease, and obesity—supporting the value of a unified framework. Conclusions: We trained separate models for each occupational health risk but deployed them in a single, real-time web application. This integrated approach improves efficiency, enables multi-outcome workforce surveillance, and supports proactive interventions in healthcare settings.

4 September 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
CBCalin Buzea
Calin Buzea
RBRazvan Buga
Razvan Buga
Maria-Alexandra PaunMaria-Alexandra Paun
Maria-Alexandra Paun
MAMadalina Albu
Madalina Albu
DIDragoș Petru Teodor Iancu
Dragoș Petru Teodor Iancu
LELucian Eva
Lucian Eva
Background: The study investigated whether three deep-learning models, namely, the CNN_model (trained from scratch), the TL_model (transfer learning), and the FT_model (fine-tuning), could predict the early response of brain metastases (BM) to radiosurgery using a minimal pre-processing of the MRI images. The dataset consisted of 19 BM patients who underwent stereotactic-radiosurgery (SRS) within 3 months. The images used included axial fluid-attenuated inversion recovery (FLAIR) sequences and high-resolution contrast-enhanced T1-weighted (CE T1w) sequences from the tumor center. The patients were classified as responders (complete or partial response) or non-responders (stable or progressive disease). Methods: A total of 2320 images from the regression class and 874 from the progression class were randomly assigned to training, testing, and validation groups. The DL models were trained using the training-group images and labels, and the validation dataset was used to select the best model for classifying the evaluation images as showing regression or progression. Results: Among the 19 patients, 15 were classified as “responders” and 4 as “non-responders”. The CNN_model achieved good performance for both classes, showing high precision, recall, and F1-scores. The overall accuracy was 0.98, with an AUC of 0.989. The TL_model performed well in identifying the “progression” class, but could benefit from improved precision, while the “regression” class exhibited high precision, but lower recall. The overall accuracy of the TL_model was 0.92, and the AUC was 0.936. The FT_model showed high recall for “progression”, but low precision, and for the “regression” class, it exhibited a high precision, but lower recall. The overall accuracy for the FT_model was 0.83, with an AUC of 0.885. Conclusions: Among the three models analyzed, the CNN_model, trained from scratch, provided the most accurate predictions of SRS responses for unlearned BM images. This suggests that CNN models could potentially predict SRS prognoses from small datasets. However, further analysis is needed, especially in cases where class imbalances exist.

14 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CVCristian Volovat
Cristian Volovat
CBCalin Buzea
Calin Buzea
DPDiana Ioana Panaite
Diana Ioana Panaite
MOMădălina Raluca Ostafe
Mădălina Raluca Ostafe
Maricel AgopMaricel Agop
Maricel Agop
SVSimona-Ruxandra Volovat
Simona-Ruxandra Volovat
Background: Survival prediction in patients with brain metastases remains a major clinical challenge, where timely and individualized prognostic estimates are critical for guiding treatment strategies and patient counseling. Methods: We propose a novel hybrid deep learning framework that integrates volumetric MRI-derived imaging biomarkers with structured clinical and demographic data to predict overall survival time. Our dataset includes 148 patients from three institutions, featuring expert-annotated segmentations of enhancing tumors, necrosis, and peritumoral edema. Two convolutional neural network backbones—ResNet-50 and EfficientNet-B0—were fused with fully connected layers processing tabular data. Models were trained using mean squared error loss and evaluated through stratified cross-validation and an independent held-out test set. Results: The hybrid model based on EfficientNet-B0 achieved state-of-the-art performance, attaining an R2 score of 0.970 and a mean absolute error of 3.05 days on the test set. Permutation feature importance highlighted edema-to-tumor ratio and enhancing tumor volume as the most informative predictors. Grad-CAM visualizations confirmed the model’s attention to anatomically and clinically relevant regions. Performance consistency across validation folds confirmed the framework’s robustness and generalizability. Conclusions: This study demonstrates that multimodal deep learning can deliver accurate, explainable, and clinically actionable survival predictions in brain metastases. The proposed framework offers a promising foundation for integration into real-world oncology workflows to support personalized prognosis and informed therapeutic decision-making.